Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium

Vinflunine is the only cytotoxic agent tested as a second line therapy in transitional cell carcinoma of the urothelium in a phase III trial. It is not largely employed in clinical practice because of the high incidence of grade 3–4 toxicity. We evaluated efficacy and safety of Vinflunine at the dos...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Schinzari, Giovanni, Rossi, Ernesto, Pierconti, Francesco, Garufi, Giovanna, Monterisi, Santa, Strippoli, Antonia, D’Argento, Ettore, Cassano, Alessandra, Barone, Carlo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2018
Konular:
Clinical Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5823567/
https://ncbi.nlm.nih.gov/pubmed/29492236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24162
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller